Tumor volume and weight were found to be significantly reduced in the sh-HE4 group compared to controls (Fig. 5A–C), consistent with previous reports indicating that HE4 promotes ovarian cancer cell proliferation. This evidence concerns the gene WFDC2 and ovarian carcinoma.